Trial Profile
A phase I trial of PPP003 for the treatment of eye pain and inflammation and dry eye
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2018
Price :
$35
*
At a glance
- Drugs Onternabez (Primary)
- Indications Dry eyes; Ocular inflammation; Ocular pain
- Focus Adverse reactions
- Sponsors Tetra Bio Pharma
- 20 Jun 2018 New trial record
- 13 Jun 2018 According to a Tetra Bio-Pharma Inc. media release, the company anticipates filing a request to commence this trial in the third quarter of 2018.